Posted on: Sunday May 9, 2021 – 3:52 PM | Last update: Sunday, May 9, 2021 – 3:53 PM
“We did not extend the request beyond the month of June,” Britton told France Inter, with regard to the contract concluded with AstraZeneca, adding: “We will see … we will see what happens.”
The AstraZeneca vaccine against the Coronavirus has been linked to a very rare risk of potential blood clots, especially for younger women, which has led some countries to limit its use to older age groups only.
Breton expressed a positive view about the quality of the doses of the “AstraZeneca” vaccine, saying, “It is a good vaccine.”
Yesterday, Saturday, the European Commission concluded an agreement with the company “Pfizer / Biontech”, which produces the vaccine against Coronavirus, to purchase up to 1.8 billion additional doses until 2023.